Christopher Murray
Director Técnico/Científico/I+D en BLUEPRINT MEDICINES CORPORATION .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Christopher Murray
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director Técnico/Científico/I+D | 10/10/2017 | - |
Historial de carrera de Christopher Murray
Antiguos cargos conocidos de Christopher Murray.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2013 | 01/05/2017 |
Formación de Christopher Murray.
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Murray
- Experiencia
